查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1914599

益智腦部補充劑市場－全球產業規模、佔有率、趨勢、機會及預測（按益智藥類型、劑型、成分類型、應用、銷售管道、地區和競爭格局分類），2021-2031年

Nootropics Brain Supplements Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type of Nootropics, By Form, By Ingredient Type, By Application, By Sales Channel, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 182 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球益智補腦產品市場預計將從2025年的95.1億美元成長到2031年的146.5億美元，複合年成長率（CAGR）為7.47%。益智補腦產品通常被稱為“聰明藥”或“認知增強劑”，是指健康人群服用以增強記憶力、創造力、動力和注意力等認知能力的天然或合成化合物。推動市場成長的主要因素包括：全球人口老化，人們希望延緩與老齡化相關的認知衰退；以及專業人士和學生為維持高效率而日益成長的需求。這些因素促使消費者持續依賴預防性腦健康策略，使該市場區別於曇花一現的健康趨勢。

市場概覽
預測期 2027-2031
市場規模：2025年 95.1億美元
市場規模：2031年 146.5億美元
複合年成長率：2026-2031年 7.47%
成長最快的細分市場 天然來源的促智藥
最大的市場 北美洲

然而，該行業面臨許多挑戰，包括監管不明晰和健康聲明檢驗，這些都可能削弱消費者信心並限制產品分銷。美國植物委員會 (ABC) 發布的《2024 年草藥市場報告》凸顯了這一趨勢，報告指出，用於認知增強的蘑菇補充劑的銷售額預計將在 2024 年飆升 114.5%，達到 765 萬美元。儘管成長迅速，但對臨床療效和標籤合規性的嚴格監管仍然是阻礙市場整體發展的主要障礙。

市場促進因素

神經退化性疾病疾病和精神疾病發病率的上升正將市場從單純的性能提升領域轉變為預防醫學的關鍵領域。隨著全球人口老化，人們認知能力下降的風險日益增加，推動了對非藥物解決方案的需求，以保護執行功能和記憶力。阿茲海默症協會發布的《2024年阿茲海默症事實與數據》報告強調了這一迫切需求，該報告估計，美國有690萬65歲及以上的老年人患有老年失智症失智症。因此，製造商面臨著開發靶向神經保護配方的壓力，並將市場從健康成年人擴展到那些希望積極管理自身長期腦健康的人。

同時，電子競技和遊戲產業正崛起為一個盈利的市場，該市場非常重視反應速度、專注力和處理速度。與傳統的運動營養產品不同，這些消費者需要專門設計的、能夠增強認知功能的產品，以便在長時間的遊戲過程中保持競爭優勢。娛樂軟體協會 (ESA) 發布的《2024 年美國電子遊戲產業基礎報告》也印證了遊戲與認知能力維持之間的協同作用，該報告顯示，37% 的玩家會透過玩遊戲來保持思維敏捷。製造商們正積極響應這一趨勢，推出面向遊戲玩家的營養補充劑，並利用責任營養委員會 (Council for Responsible Nutrition) 在 2024 年指出的一個趨勢：19% 的消費者表示，他們服用營養補充劑的主要動機是維護心理健康。

市場挑戰

全球益智腦類補充劑市場面臨的主要障礙是監管政策不明朗以及對健康聲明的嚴格驗證要求。監管機構對功效聲明設定了嚴格的標準，這使得製造商在檢驗認知增強功效的同時，也要避免產品被錯誤地歸類為藥品，從而造成了巨大的挑戰。這種監管不確定性減緩了產品創新，延緩了產品進入市場，因為企業必須嚴格遵守複雜的合規規則，以避免代價高昂的執法行動和強制產品召回。

因此，這些監管壓力削弱了消費者信任，而消費者信任對於市場的持續成長至關重要。當標籤法規限制製造商明確宣稱產品已證實的效益時，潛在客戶往往會對產品的有效性產生懷疑。這種懷疑態度對一個重要且不斷成長的消費群體構成了風險：根據責任營養委員會 (CRN) 2024 年的一份報告，19% 的膳食補充劑使用者將心理健康作為其健康管理的首要考慮因素。認知功效聲明難以達到嚴格的證據標準，這可能會疏遠這一大規模的消費群體，並可能阻礙預防性腦健康解決方案的廣泛應用。

市場趨勢

將認知支持成分融入女性健康產品正迅速成為一種顯著趨勢，其作用已從平衡激素擴展到治療特定的神經系統問題，例如執行功能障礙和腦霧。製造商日益認知到，更年期過渡會對認知功能產生深遠影響，而隨著越來越多的女性在晚年繼續從事高強度職業，這已成為一個重要問題。基於此，有些配方應運而生，將平衡荷爾蒙的適應原與促智藥結合，以增強注意力和記憶力，從而使這些產品區別於普通綜合維他命。 Bonafide Health 發布的《2024 年更年期狀況報告》凸顯了此類產品的需求，該報告發現，42% 的受訪女性表示，更年期症狀（包括認知障礙）對她們的職業抱負產生了負面影響。

同時，受片劑服用疲勞的普遍影響，以及消費者對能夠無縫融入日常生活的服用方式的偏好，市場上的補充劑形式正呈現顯著多樣化。創新產品不再局限於軟糖，而是擴展到液體補充劑、機能飲料和口腔噴霧劑等領域，這些產品具有服用方便、吸收迅速等優勢。這些新形式尤其受到生物駭客和年輕消費者的青睞，他們除了關注認知提升之外，也重視產品的高效便捷。 The Vitamin Shoppe發布的《2024年健康與保健趨勢報告》也印證了這些替代產品的商業性成功。報告指出，今年前四個月，創新、高生物有效性液體補充劑的銷量成長了25%，超過了傳統類別。

目錄

第1章概述

第2章調查方法

第3章執行摘要

第4章：客戶評價

第5章 全球益智腦部補充品市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 益智藥類型（天然益智藥、合成益智藥、混合益智藥）
    • 按劑型（膠囊/錠劑、粉末、液體）
    • 依成分類型（吡拉西坦類藥物、膽鹼來源、草藥萃取物、胺基酸、其他）
    • 使用方法（改善記憶力、專注力和專注力，改善情緒、精力和警覺性，改善睡眠，促進大腦健康，延年益壽）
    • 依銷售管道（線上零售商、藥局/藥局、其他）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

6. 北美益智腦部補充品市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

7. 歐洲益智腦部補充品市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

8. 亞太地區益智補腦產品市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

9. 中東及非洲益智藥及腦部營養補充品市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章 南美洲益智腦部補充品市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進要素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 最新進展

第13章 全球益智腦部補充品市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的可能性
  • 供應商電力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Onnit Labs, LLC
  • Hudson Aquatic Systems LLC
  • HVMN Inc.
  • Peak Nootropics
  • Nootropics Depot
  • Pure Nootropics
  • Mind Nutrition Ltd.
  • Natural Stacks LLC
  • Nootrobox
  • Mind Lab Pro

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 19840

The Global Nootropics Brain Supplements Market is projected to expand from USD 9.51 Billion in 2025 to USD 14.65 Billion by 2031, reflecting a compound annual growth rate of 7.47%. Commonly known as smart drugs or cognitive enhancers, nootropics are natural or synthetic compounds ingested by healthy individuals to boost mental capabilities like memory, creativity, motivation, and attention. Growth is primarily driven by a globally aging population aiming to delay age-associated cognitive deterioration and the escalating demands on professionals and students to sustain high productivity levels. These drivers set the market apart from fleeting wellness fads by creating a durable consumer dependency on preventative brain health strategies.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 9.51 Billion
Market Size 2031USD 14.65 Billion
CAGR 2026-20317.47%
Fastest Growing SegmentNatural Nootropics
Largest MarketNorth America

However, the sector encounters significant hurdles related to uncertain regulations and the verification of health claims, issues that can erode consumer confidence and restrict product availability. Data from the American Botanical Council's 2024 Herb Market Report highlights this dynamic, noting that sales of mushroom supplements for cognitive health surged by 114.5% in 2024, totaling $7.65 million. Despite this rapid growth, strict oversight from regulatory authorities concerning clinical efficacy and labeling compliance persists as a major barrier that threatens to slow widespread market development.

Market Driver

The rising incidence of neurodegenerative and mental health conditions is transforming the market from a niche for performance enhancement into a vital sector for preventative care. With aging populations worldwide facing elevated risks of cognitive decline, there is a growing demand for non-pharmaceutical solutions to maintain executive function and memory. This critical need is highlighted by the Alzheimer's Association's '2024 Alzheimer's Disease Facts and Figures', which estimates that 6.9 million Americans aged 65 and older suffer from Alzheimer's dementia. Consequently, manufacturers are impelled to create targeted neuroprotective formulations, thereby extending the market reach beyond healthy adults to include individuals proactively addressing long-term brain health.

Concurrently, the esports and gaming industry has emerged as a profitable demographic that values reaction time, focus, and processing speed. Unlike standard sports nutrition, these consumers require products specifically designed for cognitive outcomes to sustain a competitive edge during extended gaming sessions. This synergy between gaming and cognitive preservation is supported by the Entertainment Software Association's '2024 Essential Facts About the U.S. Video Game Industry', which reveals that 37% of players engage in gaming specifically to maintain mental sharpness. Manufacturers are responding with gamer-oriented supplements, capitalizing on a trend noted by the Council for Responsible Nutrition in 2024, where 19% of consumers identified mental health as a primary motivation for supplement use.

Market Challenge

A major obstacle confronting the Global Nootropics Brain Supplements Market is the lack of regulatory clarity and the stringent requirements for substantiating health claims. Regulatory agencies impose rigorous standards for efficacy assertions, creating a difficult environment where manufacturers struggle to verify cognitive enhancement benefits without inadvertently classifying their products as pharmaceuticals. This regulatory uncertainty slows product innovation and delays market entry, as companies must carefully navigate complex compliance rules to prevent expensive enforcement actions or mandatory product recalls.

As a result, these regulatory pressures erode consumer trust, which is essential for maintaining market growth. When labeling restrictions prevent manufacturers from clearly stating proven benefits, potential customers often doubt the product's effectiveness. This skepticism poses a risk to a vital and expanding consumer segment; the Council for Responsible Nutrition reported in 2024 that 19% of supplement users prioritize mental health in their regimen. The industry's difficulty in meeting rigorous evidentiary standards for cognitive claims threatens to alienate this large demographic, thereby hindering the broader acceptance of preventative brain health solutions.

Market Trends

The incorporation of cognitive support into women's health products is rapidly becoming a defining trend, evolving beyond hormonal balance to treat specific neurological issues such as executive dysfunction and brain fog. Manufacturers are increasingly acknowledging that the menopausal transition severely affects cognitive performance, a major concern for the growing number of women maintaining demanding careers later in life. This insight is driving the creation of formulations that blend hormone-balancing adaptogens with nootropics to support focus and memory, setting them apart from standard multivitamins. The necessity for these products is underscored by Bonafide Health's 'State of Menopause 2024' report, in which 42% of surveyed women indicated that menopausal symptoms, including cognitive disruption, negatively affected their career aspirations.

In parallel, the market is undergoing a significant diversification of delivery formats, spurred by widespread pill fatigue and a preference for consumption methods that integrate seamlessly into lifestyle routines. Innovation has expanded beyond gummies to include liquid shots, functional beverages, and oral sprays, which offer benefits like easier compliance and faster absorption. These novel formats are especially attractive to biohackers and younger demographics who value efficiency and convenience alongside cognitive enhancement. The commercial success of these alternatives is confirmed by The Vitamin Shoppe's 'Health & Wellness Trend Report 2024', which noted that sales of innovative, high-bioavailability liquid supplements rose by 25% in the first four months of the year, outpacing traditional categories.

Key Market Players

  • Onnit Labs, LLC
  • Hudson Aquatic Systems LLC
  • HVMN Inc.
  • Peak Nootropics
  • Nootropics Depot
  • Pure Nootropics
  • Mind Nutrition Ltd.
  • Natural Stacks LLC
  • Nootrobox
  • Mind Lab Pro

Report Scope

In this report, the Global Nootropics Brain Supplements Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Nootropics Brain Supplements Market, By Type of Nootropics

  • Natural Nootropics
  • Synthetic Nootropics
  • Hybrid Nootropics

Nootropics Brain Supplements Market, By Form

  • Capsules/Tablets
  • Powders
  • Liquids

Nootropics Brain Supplements Market, By Ingredient Type

  • Racetams
  • Choline Sources
  • Herbal Extracts
  • Amino Acids
  • Others

Nootropics Brain Supplements Market, By Application

  • Memory Enhancement
  • Focus and Concentration
  • Mood Enhancement
  • Energy and Alertness
  • Sleep Improvement
  • Brain Health
  • Longevity

Nootropics Brain Supplements Market, By Sales Channel

  • Online Retailers
  • Drugstores and Pharmacies
  • Others

Nootropics Brain Supplements Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Nootropics Brain Supplements Market.

Available Customizations:

Global Nootropics Brain Supplements Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Nootropics Brain Supplements Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type of Nootropics (Natural Nootropics, Synthetic Nootropics, Hybrid Nootropics)
    • 5.2.2. By Form (Capsules/Tablets, Powders, Liquids)
    • 5.2.3. By Ingredient Type (Racetams, Choline Sources, Herbal Extracts, Amino Acids, Others)
    • 5.2.4. By Application (Memory Enhancement, Focus and Concentration, Mood Enhancement, Energy and Alertness, Sleep Improvement, Brain Health, Longevity)
    • 5.2.5. By Sales Channel (Online Retailers, Drugstores and Pharmacies, Others)
    • 5.2.6. By Region
    • 5.2.7. By Company (2025)
  • 5.3. Market Map

6. North America Nootropics Brain Supplements Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type of Nootropics
    • 6.2.2. By Form
    • 6.2.3. By Ingredient Type
    • 6.2.4. By Application
    • 6.2.5. By Sales Channel
    • 6.2.6. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Nootropics Brain Supplements Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type of Nootropics
        • 6.3.1.2.2. By Form
        • 6.3.1.2.3. By Ingredient Type
        • 6.3.1.2.4. By Application
        • 6.3.1.2.5. By Sales Channel
    • 6.3.2. Canada Nootropics Brain Supplements Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type of Nootropics
        • 6.3.2.2.2. By Form
        • 6.3.2.2.3. By Ingredient Type
        • 6.3.2.2.4. By Application
        • 6.3.2.2.5. By Sales Channel
    • 6.3.3. Mexico Nootropics Brain Supplements Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type of Nootropics
        • 6.3.3.2.2. By Form
        • 6.3.3.2.3. By Ingredient Type
        • 6.3.3.2.4. By Application
        • 6.3.3.2.5. By Sales Channel

7. Europe Nootropics Brain Supplements Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type of Nootropics
    • 7.2.2. By Form
    • 7.2.3. By Ingredient Type
    • 7.2.4. By Application
    • 7.2.5. By Sales Channel
    • 7.2.6. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Nootropics Brain Supplements Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type of Nootropics
        • 7.3.1.2.2. By Form
        • 7.3.1.2.3. By Ingredient Type
        • 7.3.1.2.4. By Application
        • 7.3.1.2.5. By Sales Channel
    • 7.3.2. France Nootropics Brain Supplements Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type of Nootropics
        • 7.3.2.2.2. By Form
        • 7.3.2.2.3. By Ingredient Type
        • 7.3.2.2.4. By Application
        • 7.3.2.2.5. By Sales Channel
    • 7.3.3. United Kingdom Nootropics Brain Supplements Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type of Nootropics
        • 7.3.3.2.2. By Form
        • 7.3.3.2.3. By Ingredient Type
        • 7.3.3.2.4. By Application
        • 7.3.3.2.5. By Sales Channel
    • 7.3.4. Italy Nootropics Brain Supplements Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type of Nootropics
        • 7.3.4.2.2. By Form
        • 7.3.4.2.3. By Ingredient Type
        • 7.3.4.2.4. By Application
        • 7.3.4.2.5. By Sales Channel
    • 7.3.5. Spain Nootropics Brain Supplements Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type of Nootropics
        • 7.3.5.2.2. By Form
        • 7.3.5.2.3. By Ingredient Type
        • 7.3.5.2.4. By Application
        • 7.3.5.2.5. By Sales Channel

8. Asia Pacific Nootropics Brain Supplements Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type of Nootropics
    • 8.2.2. By Form
    • 8.2.3. By Ingredient Type
    • 8.2.4. By Application
    • 8.2.5. By Sales Channel
    • 8.2.6. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Nootropics Brain Supplements Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type of Nootropics
        • 8.3.1.2.2. By Form
        • 8.3.1.2.3. By Ingredient Type
        • 8.3.1.2.4. By Application
        • 8.3.1.2.5. By Sales Channel
    • 8.3.2. India Nootropics Brain Supplements Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type of Nootropics
        • 8.3.2.2.2. By Form
        • 8.3.2.2.3. By Ingredient Type
        • 8.3.2.2.4. By Application
        • 8.3.2.2.5. By Sales Channel
    • 8.3.3. Japan Nootropics Brain Supplements Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type of Nootropics
        • 8.3.3.2.2. By Form
        • 8.3.3.2.3. By Ingredient Type
        • 8.3.3.2.4. By Application
        • 8.3.3.2.5. By Sales Channel
    • 8.3.4. South Korea Nootropics Brain Supplements Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type of Nootropics
        • 8.3.4.2.2. By Form
        • 8.3.4.2.3. By Ingredient Type
        • 8.3.4.2.4. By Application
        • 8.3.4.2.5. By Sales Channel
    • 8.3.5. Australia Nootropics Brain Supplements Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type of Nootropics
        • 8.3.5.2.2. By Form
        • 8.3.5.2.3. By Ingredient Type
        • 8.3.5.2.4. By Application
        • 8.3.5.2.5. By Sales Channel

9. Middle East & Africa Nootropics Brain Supplements Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type of Nootropics
    • 9.2.2. By Form
    • 9.2.3. By Ingredient Type
    • 9.2.4. By Application
    • 9.2.5. By Sales Channel
    • 9.2.6. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Nootropics Brain Supplements Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type of Nootropics
        • 9.3.1.2.2. By Form
        • 9.3.1.2.3. By Ingredient Type
        • 9.3.1.2.4. By Application
        • 9.3.1.2.5. By Sales Channel
    • 9.3.2. UAE Nootropics Brain Supplements Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type of Nootropics
        • 9.3.2.2.2. By Form
        • 9.3.2.2.3. By Ingredient Type
        • 9.3.2.2.4. By Application
        • 9.3.2.2.5. By Sales Channel
    • 9.3.3. South Africa Nootropics Brain Supplements Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type of Nootropics
        • 9.3.3.2.2. By Form
        • 9.3.3.2.3. By Ingredient Type
        • 9.3.3.2.4. By Application
        • 9.3.3.2.5. By Sales Channel

10. South America Nootropics Brain Supplements Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type of Nootropics
    • 10.2.2. By Form
    • 10.2.3. By Ingredient Type
    • 10.2.4. By Application
    • 10.2.5. By Sales Channel
    • 10.2.6. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Nootropics Brain Supplements Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type of Nootropics
        • 10.3.1.2.2. By Form
        • 10.3.1.2.3. By Ingredient Type
        • 10.3.1.2.4. By Application
        • 10.3.1.2.5. By Sales Channel
    • 10.3.2. Colombia Nootropics Brain Supplements Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type of Nootropics
        • 10.3.2.2.2. By Form
        • 10.3.2.2.3. By Ingredient Type
        • 10.3.2.2.4. By Application
        • 10.3.2.2.5. By Sales Channel
    • 10.3.3. Argentina Nootropics Brain Supplements Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type of Nootropics
        • 10.3.3.2.2. By Form
        • 10.3.3.2.3. By Ingredient Type
        • 10.3.3.2.4. By Application
        • 10.3.3.2.5. By Sales Channel

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Nootropics Brain Supplements Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Onnit Labs, LLC
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Hudson Aquatic Systems LLC
  • 15.3. HVMN Inc.
  • 15.4. Peak Nootropics
  • 15.5. Nootropics Depot
  • 15.6. Pure Nootropics
  • 15.7. Mind Nutrition Ltd.
  • 15.8. Natural Stacks LLC
  • 15.9. Nootrobox
  • 15.10. Mind Lab Pro

16. Strategic Recommendations

17. About Us & Disclaimer